Abstract

Methodology. The assessment of the appropriateness of using the anti-stress pharmacological complex of SPAO for prophylactic immunization of hens with egg productivity against Newcastle disease was started at 45 days old before intramuscular vaccination against Newcastle disease with Gallimune ND vaccine at 47–48 days old. SPAO-complex — stress protector antioxidant — pharmacological complex for birds was developed at the Department of Morphology, Physiology and Pharmacology of the South Ural State Agrarian University, which was used at a dose of 185 mg/kg of body weight according to the scheme with water through a system of medications two days before, on the day of exposure and within two days after exposure to stress factors. Antibodies to the Newcastle disease virus were tested by hem agglutination inhibition test. Results. As a result, it was proved that vaccinations by parenteral administration of vaccines cause the development of non-specific adaptive reactions in chickens. The level of development of reactions corresponds to the formation of stress. The use of the SPAO-complex reduces the immunosuppressive effect of the hypothalamic-pituitaryadrenal system during the development of adaptive reactions in birds under industrial stresses. In the prophylaxis of Newcastle disease chickens of the egg productivity direction on the background of stress prevention by the pharmacological complex of SPAO antibody production is more uniform throughout the herd. In the experimental group, titers are in the range of 9.40–13.40 log2, in the control group — 8.52–12.36. The level of statistical differences in the intensity of antibody production log2 is at the level of P = 0.0277. After transferring the hens to the production shop in the experimental group a higher level of productivity is noted compared to the control: egg production in the experimental group is 2.04% higher, the livestock safety over the period from 105 to 250 days of life of hens reached the highest values in the experimental group and amounted to 99.72%, in the control group — 99.44%.

Highlights

  • SPAO-complex — stress protector antioxidant — pharmacological complex for birds was developed at the Department of Morphology, Physiology and Pharmacology of the South Ural State Agrarian University, which was used at a dose of 185 mg/kg of body weight according to the scheme with water through a system of medications two days before, on the day of exposure and within two days after exposure to stress factors

  • It was proved that vaccinations by parenteral administration of vaccines cause the development of non-specific adaptive reactions in chickens

  • The use of the SPAO-complex reduces the immunosuppressive effect of the hypothalamic-pituitaryadrenal system during the development of adaptive reactions in birds under industrial stresses

Read more

Summary

ВVЕETEТRINЕARРY PИHAНRMАACOРLOИGYЯ

Влияние антистрессового фармакологического комплекса «СПАО» на эффективность профилактической иммунизации кур против болезни Ньюкасла. Оценку целесообразности применения антистрессового фармакологического комплекса СПАО при профилактической иммунизации кур яичного направления продуктивности против болезни Ньюкасла начинали в 45-суточном возрасте, перед внутримышечной вакцинацией против болезни Ньюкасла вакциной Gallimune ND в 47–48-суточном возрасте. Использование СПАО-комплекс позволяет снизить иммуносупрессивное влияние гипоталамо-гипофизарно-надпочечниковой системы в период развития адаптационных реакций у птиц в условиях промышленных стрессов. При профилактике болезни Ньюкасла кур яичного направления продуктивности на фоне профилактики стрессов фармакологическим комплексом СПАО выработка антител более однородна по всему стаду. Уровень статистических различий интенсивности выработки антител log находится на уровне Р = 0,0277. После перевода кур в цех получения продукции в опытной группе по сравнению с контрольной отмечается более высокий уровень продуктивности: яйценоскость выше в опытной группе на 2,04%, сохранность поголовья за период с 105 по 250 сутки жизни кур наиболее высоких значений достигала в опытной группе и составил 99,72%, в контрольной группе — 99,44%

ВЕТЕРИНАРНАЯ ФАРМАКОЛОГИЯ
Results
Введение расте перед внутримышечной вакцинацией против
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call